Post-COVID cognitive dysfunction: current status and research recommendations for high risk population

被引:43
|
作者
Quan, Meina [1 ,2 ,3 ,4 ]
Wang, Xuechu [1 ,2 ]
Gong, Min [1 ,2 ]
Wang, Qi [1 ,2 ,3 ,4 ]
Li, Yan [1 ,2 ]
Jia, Jianping [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Innovat Ctr Neurol Disorders, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[3] Natl Ctr Neurol Disorders, Beijing, Peoples R China
[4] Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China
[5] Betjing Key Lab Geriatr Cognit Disorders, Beijing, Peoples R China
[6] Capital Med Univ, Clin Ctr Neurodegenerat Dis & Memory Impairment, Beijing, Peoples R China
[7] Capital Med Univ, Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Collaborat Innovat Ctr Brain Disorders, Beijing, Peoples R China
[8] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China
[9] Capital Med Univ, Xuanwu Hosp, Innovat Ctr Neurol Disorders, Beijing 100053, Peoples R China
[10] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing 100053, Peoples R China
来源
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2023年 / 38卷
基金
中国国家自然科学基金;
关键词
Long COVID; Post-COVID cognitive dysfunction; Epidemiology; Diagnosis; Risk factors; Management; ALZHEIMERS-DISEASE; HEALTH; METAANALYSIS; INFECTIONS; IMPAIRMENT; CARE;
D O I
10.1016/j.lanwpc.2023.100836
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Post-COVID cognitive dysfunction (PCCD) is a condition in which patients with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, usually three months from the onset, exhibit subsequent cognitive impairment in various cognitive domains, and cannot be explained by an alternative diagnosis. While our knowledge of the risk factors and management strategy of PCCD is still incomplete, it is necessary to integrate current epide-miology, diagnosis and treatment evidence, and form consensus criteria to better understand this disease to improve disease management. Identifying the risk factors and vulnerable population of PCCD and providing reliable stra-tegies for effective prevention and management is urgently needed. In this paper, we reviewed epidemiology, diagnostic markers, risk factors and available treatments on the disease, formed research recommendation frame-work for vulnerable population, under the background of post-COVID period.Copyright & COPY; 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study
    Kim, Sung-a
    Maeda, Megumi
    Murata, Fumiko
    Fukuda, Haruhisa
    VACCINE, 2025, 43
  • [32] Reconsidering research exclusion for serious mental illness: Ethical principles, current status, and recommendations
    Harris, J. Irene
    Hanson, Devin
    Leskela, Jennie
    Billig, John
    Padilla-Martinez, Viviana
    Boyd, Jennifer
    Nienow, Tasha
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 143 : 138 - 143
  • [33] Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study
    Alex Buoite Stella
    Giovanni Furlanis
    Nicolò Arjuna Frezza
    Romina Valentinotti
    Milos Ajcevic
    Paolo Manganotti
    Journal of Neurology, 2022, 269 : 587 - 596
  • [34] Post-COVID Postural Orthostatic Tachycardia Syndrome and Inappropriate Sinus Tachycardia in the Pediatric Population
    Francesco Raffaele Spera
    Raffaella Mistrulli
    Luigi Salerno
    Federico Vannini
    Melwyn Luis Muthukkattil
    Roberta Falcetti
    Terry Segal
    Emanuele Barbato
    Danilo Buonsenso
    Current Clinical Microbiology Reports, 2024, 11 : 115 - 125
  • [35] High prevalence of cardiac post-acute sequelae in patients recovered from Covid-19. Results from the ARCA post-COVID study
    Antoncecchi, Valeria
    Antoncecchi, Ettore
    Orsini, Enrico
    D'Ascenzo, Giuseppe
    Oliviero, Ugo
    Savino, Ketty
    Aloisio, Angelo
    Casalino, Laura
    Lillo, Adele
    Chiuini, Emilia
    Santoro, Giosue
    Manfre, Vincenzo
    Rizzo, Valeria
    Zito, Giovanni Battista
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2024, 21
  • [36] Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status
    Nehme, Mayssam
    Vetter, Pauline
    Chappuis, Francois
    Kaiser, Laurent
    Guessous, Idris
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (09) : 1567 - 1575
  • [37] Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study
    Buoite Stella, Alex
    Furlanis, Giovanni
    Frezza, Nicolo Arjuna
    Valentinotti, Romina
    Ajcevic, Milos
    Manganotti, Paolo
    JOURNAL OF NEUROLOGY, 2022, 269 (02) : 587 - 596
  • [38] Neuropsychological measures of post-COVID-19 cognitive status
    Lauria, Alessandra
    Carfi, Angelo
    Benvenuto, Francesca
    Bramato, Giulia
    Ciciarello, Francesca
    Rocchi, Sara
    Rota, Elisabetta
    Salerno, Andrea
    Stella, Leonardo
    Tritto, Marcello
    Di Paola, Antonella
    Pais, Cristina
    Tosato, Matteo
    Janiri, Delfina
    Sani, Gabriele
    Lo Monaco, Rita C.
    Pagano, Francesco
    Fantoni, Massimo
    Bernabei, Roberto
    Landi, Francesco
    Bizzarro, Alessandra
    FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [39] Functional neuroimaging in subjective cognitive decline: current status and a research path forward
    Viviano, Raymond P.
    Damoiseaux, Jessica S.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [40] Patients' Experiences With Therapeutic Approaches for Post-COVID Syndrome: Results of a Crowdsourced Research Survey
    Klocke, Carina
    Valentini, Jan
    Stolz, Regina
    Gassner, Lena
    Joos, Stefanie
    Foerster, Christian
    ANNALS OF FAMILY MEDICINE, 2023, 21 (01) : 73 - 75